BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carino A, Biagioli M, Marchianò S, Fiorucci C, Zampella A, Monti MC, Scarpelli P, Ricci P, Distrutti E, Fiorucci S. Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH. Biochim Biophys Acta Mol Cell Biol Lipids 2019;1864:1422-37. [PMID: 31325638 DOI: 10.1016/j.bbalip.2019.07.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang R, Wang L, Wu H, Zhang L, Hu X, Li C, Liu S. Noni (Morinda citrifolia L.) fruit phenolic extract supplementation ameliorates NAFLD by modulating insulin resistance, oxidative stress, inflammation, liver metabolism and gut microbiota. Food Research International 2022;160:111732. [DOI: 10.1016/j.foodres.2022.111732] [Reference Citation Analysis]
2 Lin X, Mai M, He T, Huang H, Zhang P, Xia E, Guo H. Efficiency of ursodeoxycholic acid for the treatment of nonalcoholic steatohepatitis: A systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol 2022;:1-9. [PMID: 35617696 DOI: 10.1080/17474124.2022.2083605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Dong Z, Zhang D, Wu X, Yin Y, Wan D. Ferrous Bisglycinate Supplementation Modulates Intestinal Antioxidant Capacity via the AMPK/FOXO Pathway and Reconstitutes Gut Microbiota and Bile Acid Profiles in Pigs. J Agric Food Chem 2022. [PMID: 35420025 DOI: 10.1021/acs.jafc.2c00138] [Reference Citation Analysis]
4 Chiang JY, Ferrell JM. Discovery of farnesoid X receptor and its role in bile acid metabolism. Molecular and Cellular Endocrinology 2022. [DOI: 10.1016/j.mce.2022.111618] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
5 Zhang F, Xiao X, Li Y, Wu H, Deng X, Jiang Y, Zhang W, Wang J, Ma X, Zhao Y. Therapeutic Opportunities of GPBAR1 in Cholestatic Diseases. Front Pharmacol 2021;12:805269. [PMID: 35095513 DOI: 10.3389/fphar.2021.805269] [Reference Citation Analysis]
6 Xu F, Wang J, Wang P, Hou T, Zhou H, Zhao Y, Wang J, Liu Y, Liang X. Ursodesoxycholic acid is an FFA4 agonist and reduces hepatic steatosis via FFA4 signaling. Eur J Pharmacol 2022;:174760. [PMID: 35033554 DOI: 10.1016/j.ejphar.2022.174760] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li H, Wang Q, Chen P, Zhou C, Zhang X, Chen L. Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model. Front Pharmacol 2021;12:788558. [PMID: 34938193 DOI: 10.3389/fphar.2021.788558] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Ferrell JM, Chiang JY. Bile acid receptors and signaling crosstalk in the liver, gut and brain. Liver Research 2021;5:105-18. [DOI: 10.1016/j.livres.2021.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Li WC, Zhao SX, Ren WG, Zhang YG, Wang RQ, Kong LB, Zhang QS, Nan YM. Co-administration of obeticholic acid and simvastatin protects against high-fat diet-induced non-alcoholic steatohepatitis in mice. Exp Ther Med 2021;22:830. [PMID: 34149876 DOI: 10.3892/etm.2021.10262] [Reference Citation Analysis]
10 Sun R, Xu C, Feng B, Gao X, Liu Z. Critical roles of bile acids in regulating intestinal mucosal immune responses. Therap Adv Gastroenterol 2021;14:17562848211018098. [PMID: 34104213 DOI: 10.1177/17562848211018098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
11 Winston JA, Rivera A, Cai J, Patterson AD, Theriot CM. Secondary bile acid ursodeoxycholic acid alters weight, the gut microbiota, and the bile acid pool in conventional mice. PLoS One 2021;16:e0246161. [PMID: 33600468 DOI: 10.1371/journal.pone.0246161] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Yin Y, Wang M, Gu W, Chen L. Intestine-specific FXR agonists as potential therapeutic agents for colorectal cancer. Biochem Pharmacol 2021;186:114430. [PMID: 33556338 DOI: 10.1016/j.bcp.2021.114430] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
13 Fiorucci S, Carino A, Baldoni M, Santucci L, Costanzi E, Graziosi L, Distrutti E, Biagioli M. Bile Acid Signaling in Inflammatory Bowel Diseases. Dig Dis Sci 2021;66:674-93. [PMID: 33289902 DOI: 10.1007/s10620-020-06715-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 15.0] [Reference Citation Analysis]
14 Carino A, Moraca F, Fiorillo B, Marchianò S, Sepe V, Biagioli M, Finamore C, Bozza S, Francisci D, Distrutti E, Catalanotti B, Zampella A, Fiorucci S. Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain. Front Chem 2020;8:572885. [PMID: 33195060 DOI: 10.3389/fchem.2020.572885] [Cited by in Crossref: 20] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
15 Fiorucci S, Baldoni M, Ricci P, Zampella A, Distrutti E, Biagioli M. Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders. Current Opinion in Pharmacology 2020;53:45-54. [DOI: 10.1016/j.coph.2020.04.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
16 Wu P, Zhao J, Guo Y, Yu Y, Wu X, Xiao H. Ursodeoxycholic acid alleviates nonalcoholic fatty liver disease by inhibiting apoptosis and improving autophagy via activating AMPK. Biochem Biophys Res Commun 2020;529:834-8. [PMID: 32595039 DOI: 10.1016/j.bbrc.2020.05.128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Fiorucci S, Biagioli M, Sepe V, Zampella A, Distrutti E. Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH). Expert Opin Investig Drugs 2020;29:623-32. [PMID: 32552182 DOI: 10.1080/13543784.2020.1763302] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
18 Thounaojam MC, Jadeja RN, Rajpurohit S, Gutsaeva DR, Stansfield BK, Martin PM, Bartoli M. Ursodeoxycholic Acid Halts Pathological Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy. J Clin Med 2020;9:E1921. [PMID: 32575487 DOI: 10.3390/jcm9061921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Meadows V, Kennedy L, Kundu D, Alpini G, Francis H. Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases. Front Med (Lausanne) 2020;7:15. [PMID: 32064266 DOI: 10.3389/fmed.2020.00015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
20 [DOI: 10.1101/2020.06.10.144964] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]